Table 1.
Demographic and glaucoma status data of subjects in the study sample. Mean values are reported with standard deviations (SD).
Characteristic | Value (N=133 subjects) | |
Gender, n (%) | ||
Male | 47 (35.3) | |
Female | 86 (64.7) | |
Age (yr), mean (SD) | 60.9 (10.51) | |
Right Eye (N=133) | Left Eye (N=132) | |
Number of glaucoma medications, n (%) | ||
0 | 8 (6.0) | 7 (5.3) |
1 | 102 (76.7) | 103 (78.0) |
2 | 19 (14.3) | 18 (13.7) |
3 | 4 (4.0) | 4 (3.0) |
Glaucoma medication classes, n (%) | ||
Beta-blockers | 79 (59.4) | 79 (59.9) |
Prostaglandins | 51 (38.4) | 50 (37.9) |
Carbonic anhydrase inhibitors | 9 (6.8) | 9 (6.8) |
Adrenergic agonists | 10 (7.5) | 10 (7.6) |
Central corneal thickness (μm), mean (SD) | 535.9 (35.9) | 537.5 (46.5) |
Vertical cup-disc ratio, mean (SD) | 0.63 (0.14) | 0.63 (0.13) |
Visual field mean deviation (dB), mean (SD) | −4.18 (5.14) | −4.07 (4.24) |
Laser parameters, mean (SD) | ||
Total energy (milllijoules) | 82.5 (18.8) | 87.0 (18.5) |
Number of treatment spots | 103.3 (3.5) | 103.1 (3.1) |